Robotic prostate surgery has become one of the most advanced options in prostate canc...
Sickle cell disease (SCD) is a genetic disorder that affects millions of people worldwide. It causes red blood cells to take on an abnormal, crescent, or sickle shape, which can lead to several complications such as pain episodes, organ damage, and increased risk of infection. While there are treatments that help manage the symptoms, a bone marrow transplant (BMT) offers the potential for a permanent cure. But how exactly does a bone marrow transplant treat sickle cell disease? Let’s explore how this groundbreaking procedure works and how it has become a promising option for many patients.
To understand the potential of bone marrow transplantation to treat sickle cell disease, we need to fully understand the pathology of the disease. Sickle cell disease is a genetic disease that is caused by mutations in the gene that codes for hemoglobin. Hemoglobin is a protein in red blood cells that transports oxygen from the lungs to the rest of the body. This mutated hemoglobin is called hemoglobin S. As a result, these red cells become abnormally rigid and bend in the sickle shape. This will block the blood vessels, set off periods of painful crises over and over, and disrupt blood flow throughout the body with a severe oxygen deficit in a damage chain reaction.
Quite slowly, these recurrently blocked blood supplies and later oxygen shortages start giving birth to distressing conditions: organ harm, heart and brain attack, and elevated susceptibility to infections. Treatments currently available, such as blood transfusions and medications like hydroxyurea, are for the relief of symptoms but do not cure the disease.
Bone marrow transplantation, or hematopoietic stem cell transplantation (HSCT), is a method that replaces a patient's diseased or damaged bone marrow with healthy stem cells, either from a donor or a patient. Bone marrow is the spongy tissue inside your bones where blood cells are made. The stem cells coming from the marrow can mature into red blood cells, white blood cells, and platelets, which are crucial for a healthy circulatory and immune system.
In the course of sickle cell disease, the purpose of performing a bone marrow transplant is to give rise to a patient with bone marrow that is devoid of all suitable stem cells capable of producing normal red blood cells to effectively cure sickle cell disease.
A bone marrow transplant gives the patient another chance. Now let's see the process of treating sickle cell disease:
In many sickle cell disease patients, HCT will forever be the sure cure for sickle cell disease. After a bone marrow transplantation, the patient's body will begin to produce well-formed blood cells without any sickling pathology encountered in this disease.
Nonetheless, bone marrow transplantation has its disincentives. The initiative poses some danger, particularly from rejection, infection, and other complications including from the conditioning regimen. Many with sickle cell disease will not be able to find compatible donors, it is also an expensive and a huge commitment, requiring months and months of being in and out of the hospital.
Ongoing research is improving the success of its use, and access to bone marrow transplantation among larger populations, while gene therapy too is seen as another approach that targets mutation correction of sickle cell disease without demanding the need for bone marrow transplantation.
For those who are eligible and able to take part in the treatment procedure, bone marrow transplantation offers a ray of hope. Case studies of patients who have received this treatment show that the procedures were not only able to relieve symptoms for patients but have allowed them a complete recovery in the future.
Bone marrow transplant agrees to save the day for sickle cell disease by replacing the defective bone marrow with a rapidly dividing, self-renewing leukemia, specifically hematopoietic stem cells that differentiate into normal, functional; red blood cells. Bone marrow transplantation, though complex, risky, and demanding, offers its beneficiaries a small piece of heaven away from genetic diseases throughout their lives. As time transpires around scientific advancements, it is hoped that more people will have access to this life-saving therapy, beginning to turn the page on the story of sickle cell.
If you or someone you know is affected by sickle cell disease, it is important to talk with your healthcare team to discuss the BMT as an option.
Prepared by the Medical Editorial Board. Our health library contents have been prepared for informational purposes only and with the scientific content on the registration date. For all your questions, concerns, diagnosis or treatment about your health, please consult your doctor or health institution.